Expression signatures of metastatic capacity in a genetic mouse model of lung adenocarcinoma

Don L. Gibbons, Wei Lin, Chad J. Creighton, Shuling Zheng, Dror Berel, Yanan D Yang, Maria Gabriela Raso, Diane D. Liu, Ignacio I. Wistuba, Guillermina Lozano, Jonathan M. Kurie

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Background: Non-small cell lung cancer (NSCLC) is the foremost cause of cancer-related death in Western countries, which is due partly to the propensity of NSCLC cells to metastasize. The biologic basis for NSCLC metastasis is not well understood. Methodology/Principal Findings: Here we addressed this deficiency by transcriptionally profiling tumors from a genetic mouse model of human lung adenocarcinoma that develops metastatic disease owing to the expression of K-rasG12D and p53R172H. We identified 2,209 genes that were differentially expressed in distant metastases relative to matched lung tumors. Mining of publicly available data bases revealed this expression signature in a subset of NSCLC patients who had a poorer prognosis than those without the signature. Conclusions/Significance: These findings provide evidence that K-rasG12D; p53R172H mice recapitulate features of human NSCLC metastasis and will provide a useful platform on which to study the biologic basis for lung adenocarcinoma metastasis and its prevention by novel agents.

Original languageEnglish (US)
Article numbere5401
JournalPLoS One
Volume4
Issue number4
DOIs
StatePublished - Apr 30 2009
Externally publishedYes

Fingerprint

Genetic Models
lung neoplasms
adenocarcinoma
Non-Small Cell Lung Carcinoma
Tumors
animal models
lungs
Cells
metastasis
Neoplasm Metastasis
Genes
cells
Neoplasms
neoplasms
prognosis
Adenocarcinoma of lung
Databases
Lung
death
mice

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Gibbons, D. L., Lin, W., Creighton, C. J., Zheng, S., Berel, D., Yang, Y. D., ... Kurie, J. M. (2009). Expression signatures of metastatic capacity in a genetic mouse model of lung adenocarcinoma. PLoS One, 4(4), [e5401]. https://doi.org/10.1371/journal.pone.0005401

Expression signatures of metastatic capacity in a genetic mouse model of lung adenocarcinoma. / Gibbons, Don L.; Lin, Wei; Creighton, Chad J.; Zheng, Shuling; Berel, Dror; Yang, Yanan D; Raso, Maria Gabriela; Liu, Diane D.; Wistuba, Ignacio I.; Lozano, Guillermina; Kurie, Jonathan M.

In: PLoS One, Vol. 4, No. 4, e5401, 30.04.2009.

Research output: Contribution to journalArticle

Gibbons, DL, Lin, W, Creighton, CJ, Zheng, S, Berel, D, Yang, YD, Raso, MG, Liu, DD, Wistuba, II, Lozano, G & Kurie, JM 2009, 'Expression signatures of metastatic capacity in a genetic mouse model of lung adenocarcinoma', PLoS One, vol. 4, no. 4, e5401. https://doi.org/10.1371/journal.pone.0005401
Gibbons, Don L. ; Lin, Wei ; Creighton, Chad J. ; Zheng, Shuling ; Berel, Dror ; Yang, Yanan D ; Raso, Maria Gabriela ; Liu, Diane D. ; Wistuba, Ignacio I. ; Lozano, Guillermina ; Kurie, Jonathan M. / Expression signatures of metastatic capacity in a genetic mouse model of lung adenocarcinoma. In: PLoS One. 2009 ; Vol. 4, No. 4.
@article{9aa68ea284d54a77a25744333065d914,
title = "Expression signatures of metastatic capacity in a genetic mouse model of lung adenocarcinoma",
abstract = "Background: Non-small cell lung cancer (NSCLC) is the foremost cause of cancer-related death in Western countries, which is due partly to the propensity of NSCLC cells to metastasize. The biologic basis for NSCLC metastasis is not well understood. Methodology/Principal Findings: Here we addressed this deficiency by transcriptionally profiling tumors from a genetic mouse model of human lung adenocarcinoma that develops metastatic disease owing to the expression of K-rasG12D and p53R172H. We identified 2,209 genes that were differentially expressed in distant metastases relative to matched lung tumors. Mining of publicly available data bases revealed this expression signature in a subset of NSCLC patients who had a poorer prognosis than those without the signature. Conclusions/Significance: These findings provide evidence that K-rasG12D; p53R172H mice recapitulate features of human NSCLC metastasis and will provide a useful platform on which to study the biologic basis for lung adenocarcinoma metastasis and its prevention by novel agents.",
author = "Gibbons, {Don L.} and Wei Lin and Creighton, {Chad J.} and Shuling Zheng and Dror Berel and Yang, {Yanan D} and Raso, {Maria Gabriela} and Liu, {Diane D.} and Wistuba, {Ignacio I.} and Guillermina Lozano and Kurie, {Jonathan M.}",
year = "2009",
month = "4",
day = "30",
doi = "10.1371/journal.pone.0005401",
language = "English (US)",
volume = "4",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "4",

}

TY - JOUR

T1 - Expression signatures of metastatic capacity in a genetic mouse model of lung adenocarcinoma

AU - Gibbons, Don L.

AU - Lin, Wei

AU - Creighton, Chad J.

AU - Zheng, Shuling

AU - Berel, Dror

AU - Yang, Yanan D

AU - Raso, Maria Gabriela

AU - Liu, Diane D.

AU - Wistuba, Ignacio I.

AU - Lozano, Guillermina

AU - Kurie, Jonathan M.

PY - 2009/4/30

Y1 - 2009/4/30

N2 - Background: Non-small cell lung cancer (NSCLC) is the foremost cause of cancer-related death in Western countries, which is due partly to the propensity of NSCLC cells to metastasize. The biologic basis for NSCLC metastasis is not well understood. Methodology/Principal Findings: Here we addressed this deficiency by transcriptionally profiling tumors from a genetic mouse model of human lung adenocarcinoma that develops metastatic disease owing to the expression of K-rasG12D and p53R172H. We identified 2,209 genes that were differentially expressed in distant metastases relative to matched lung tumors. Mining of publicly available data bases revealed this expression signature in a subset of NSCLC patients who had a poorer prognosis than those without the signature. Conclusions/Significance: These findings provide evidence that K-rasG12D; p53R172H mice recapitulate features of human NSCLC metastasis and will provide a useful platform on which to study the biologic basis for lung adenocarcinoma metastasis and its prevention by novel agents.

AB - Background: Non-small cell lung cancer (NSCLC) is the foremost cause of cancer-related death in Western countries, which is due partly to the propensity of NSCLC cells to metastasize. The biologic basis for NSCLC metastasis is not well understood. Methodology/Principal Findings: Here we addressed this deficiency by transcriptionally profiling tumors from a genetic mouse model of human lung adenocarcinoma that develops metastatic disease owing to the expression of K-rasG12D and p53R172H. We identified 2,209 genes that were differentially expressed in distant metastases relative to matched lung tumors. Mining of publicly available data bases revealed this expression signature in a subset of NSCLC patients who had a poorer prognosis than those without the signature. Conclusions/Significance: These findings provide evidence that K-rasG12D; p53R172H mice recapitulate features of human NSCLC metastasis and will provide a useful platform on which to study the biologic basis for lung adenocarcinoma metastasis and its prevention by novel agents.

UR - http://www.scopus.com/inward/record.url?scp=65549137486&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65549137486&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0005401

DO - 10.1371/journal.pone.0005401

M3 - Article

VL - 4

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 4

M1 - e5401

ER -